San Diego, California, United States The typical case for the fund is to invest in rounds with 4 participants. Despite the Tang Capital Management, startups are often financed by ProQuest Investments, Fonds de solidaritu00e9 FTQ, Adams Street Partners. The meaningful sponsors for the fund in investment in the same round are Adams Street Partners, Venrock Healthcare Partners, Tavistock Life Sciences. In the next rounds fund is usually obtained by Next47, Ampersand Capital Partners, Adams Street Partners.
The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013. The top activity for fund was in 2019. This Tang Capital Management works on 21 percentage points more the average amount of lead investments comparing to the other organizations.
We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight MethylGene, RadPharm, Attune Pharmaceuticals. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
We also calculated 5 valuable employees in our database.
Related Funds
| Fund Name | Location |
| C4D Partners | Amsterdam, Noord-Holland, The Netherlands |
| Egis Technology | Taipei, Taiwan |
| Hunan Hi-Tech Venture Capital | China, Fujian, Hunan |
| Innogy Venture Capital | Essen, Germany, Nordrhein-Westfalen |
| IXcore | France, Ile-de-France, Marly-le-roi |
| Lanqi Investment | - |
| Menterra Venture Advisors | Bengaluru, India, Karnataka |
| National Cancer Institute SBIR Development Center | - |
| NGP Energy Capital Management | Irving, Texas, United States |
| Pod Investment | Stockholm, Stockholm County, Sweden |
| RIMU Group | Central, Central Region, Singapore |
| Shanda Capital | China, Shanghai |
| SigmaLabs | Israel, Ramat Gan, Tel Aviv |
| stakefish | Seoul, Seoul-t'ukpyolsi, South Korea |
| Swissfirst Bank AG | Switzerland, Zürich, Zurich |
| Vesbridge Partners | Massachusetts, United States, Wakefield |
| WestView Capital Partners | Boston, Massachusetts, United States |
| Yamas Ventures GmbH | - |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Attune Pharmaceuticals | $23M | 23 Jan 2019 | New York, New York, United States | ||
RadPharm | $10M | 28 Nov 2007 | Belconnen, Australian Capital Territory, Australia | ||
RadPharm | $8M | 01 Mar 2006 | Belconnen, Australian Capital Territory |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Attune Pharmaceuticals | $23M | 23 Jan 2019 | New York, New York, United States | ||
RadPharm | $10M | 28 Nov 2007 | Belconnen, Australian Capital Territory, Australia | ||
RadPharm | $8M | 01 Mar 2006 | Belconnen, Australian Capital Territory |
